Earlier diagnosis for faster treatment and better outcome

Heart failure

Pronota’s novel heart failure markers can improve the diagnosis and patient management of acute heart failure by overcoming some of the specificity issues related to currently used heart failure markers.

more...

Pre-eclampsia

Pronota has identified a combination of protein biomarkers that identifies women at risk of developing pre-eclampsia. Pronota’s test will allow health care providers to personalize neonatal care, prevent many of the adverse outcomes and reduce the staggering health care cost.

more...

Sepsis

Sepsis (also called blood poisoning) is a life threatening medical condition characterized by a systemic host response to infection, which can lead to organ failure and death in severe cases.

more...

Pipeline

Pronota is developing novel protein diagnostic blood tests in areas with significant unmet medical need.

more...